We are live on ! Find out more
PIM

Penobscot Investment Management Portfolio holdings

AUM $1.46B
1-Year Est. Return 32.32%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+32.32%
3 Year Est. Return
+103.46%
5 Year Est. Return
+129.15%
10 Year Est. Return
+393.77%
AUM
$318M
AUM Growth
+$16.7M
Cap. Flow
+$3.47M
Cap. Flow %
1.09%
Top 10 Hldgs %
26.12%
Holding
190
New
10
Increased
61
Reduced
58
Closed
4

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$1.09M
2
ADP icon
Automatic Data Processing
ADP
+$695K
3
IBM icon
IBM
IBM
+$621K
4
SIAL
SIGMA - ALDRICH CORP
SIAL
+$564K
5
FLS icon
Flowserve
FLS
+$341K

Sector Composition

Rank Sector Weight
1 Healthcare 16.64%
2 Industrials 15.26%
3 Technology 11.1%
4 Financials 10.07%
5 Consumer Staples 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$336B
$12.1M 3.81%
132,959
-535
-0.4% -$47.1K
XOM icon
2
ExxonMobil
XOM
$644B
$12.1M 3.79%
130,475
-3,567
-3% -$333K
JNJ icon
3
Johnson & Johnson
JNJ
$618B
$10.1M 3.17%
96,497
+735
+0.8% +$77.5K
CVX icon
4
Chevron
CVX
$392B
$7.75M 2.44%
69,081
+1,050
+2% +$119K
RTX icon
5
RTX Corp
RTX
$290B
$7.56M 2.38%
104,488
-604
-0.6% -$41.2K
MMM icon
6
3M
MMM
$90.9B
$7.22M 2.27%
52,550
-647
-1% -$83K
CVS icon
7
CVS Health
CVS
$133B
$7.19M 2.26%
74,649
+1,640
+2% +$145K
NEE icon
8
NextEra Energy
NEE
$181B
$7.09M 2.23%
266,936
+820
+0.3% +$20.7K
IBM icon
9
IBM
IBM
$211B
$6.2M 1.95%
40,387
-3,905
-9% -$621K
ABBV icon
10
AbbVie
ABBV
$443B
$5.77M 1.82%
88,194
+1,095
+1% +$69K
NKE icon
11
Nike
NKE
$61.9B
$5.57M 1.75%
115,950
-1,070
-0.9% -$50.2K
T icon
12
AT&T
T
$159B
$5.27M 1.66%
207,692
-2,369
-1% -$61.5K
ADP icon
13
Automatic Data Processing
ADP
$106B
$5.26M 1.65%
63,080
-8,580
-12% -$695K
AAPL icon
14
Apple
AAPL
$4.54T
$4.85M 1.53%
175,884
+4,140
+2% +$113K
PEP icon
15
PepsiCo
PEP
$190B
$4.84M 1.52%
51,179
+50
+0.1% +$4.79K
DIS icon
16
Walt Disney
DIS
$167B
$4.77M 1.5%
50,676
+1,195
+2% +$108K
MSFT icon
17
Microsoft
MSFT
$3.45T
$4.7M 1.48%
101,288
+3,130
+3% +$147K
GE icon
18
GE Aerospace
GE
$374B
$4.52M 1.42%
37,350
+15
+0% +$1.84K
INTC icon
19
Intel
INTC
$455B
$4.46M 1.4%
122,759
-348
-0.3% -$12.1K
UNP icon
20
Union Pacific
UNP
$174B
$4.14M 1.3%
34,768
+60
+0.2% +$6.89K
CB
21
DELISTED
CHUBB CORPORATION
CB
$4.08M 1.28%
39,438
-1,010
-2% -$101K
ABT icon
22
Abbott
ABT
$183B
$3.91M 1.23%
86,785
+640
+0.7% +$27.9K
PFE icon
23
Pfizer
PFE
$143B
$3.81M 1.2%
129,080
-5,692
-4% -$163K
SHW icon
24
Sherwin-Williams
SHW
$82.7B
$3.68M 1.16%
41,925
+240
+0.6% +$18.9K
CSX icon
25
CSX Corp
CSX
$93.4B
$3.66M 1.15%
303,411

Similar funds

Penobscot Investment Management's Q4 2014 Portfolio in Review

As of Q4 2014, Penobscot Investment Management held 190 positions worth $318M, up 5.5% from $301M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Penobscot Investment Management's Q4 2014 filing shows 10 new, 61 increased, 58 reduced and 4 closed positions. Its largest new stake was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 11,825 shares worth $1.2M. The largest sale was Sanofi, an estimated $1.09M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.

  • Penobscot Investment Management's largest Q4 2014 buy was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund: 11,825 shares worth $1.2M.
  • Penobscot Investment Management added most to Vanguard Short-Term Bond ETF in Q4 2014, an estimated $1.18M increase.
  • Penobscot Investment Management's biggest Q4 2014 reduction was Sanofi, cutting an estimated $1.09M.
  • Penobscot Investment Management fully exited Flowserve in Q4 2014, selling an estimated $341K.
  • Penobscot Investment Management's ten largest holdings make up 26% of its $318M portfolio in Q4 2014.
  • Penobscot Investment Management opened 10 new positions and closed 4 in Q4 2014.
  • Penobscot Investment Management's portfolio value rose 5.5% quarter-over-quarter to $318M.

Based on Penobscot Investment Management's 13F filing for Q4 2014, filed 11 Feb 2015.